Innospec Inc.

IOSP
Delayed Nasdaq - 04/06 10:00:00 pm
69.58USD
+8.48%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2019 2020 (e)
Sales 1 513 1 455
EBITDA 202 185
Operating profit (EBIT) 150 132
Pre-Tax Profit (EBT) 150 116
Net income 112 84,8
P/E ratio 22,8x 19,2x
EPS ( $ ) 4,54 3,43
Dividend per Share ( $ ) - 1,04
Yield - 1,58%
Reference price ( $ ) 103,440 65,810
Announcement Date 02/18/2020
05:00am
-
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 2019 2020 (e)
Debt - -
Finance 0,00 0,00
Operating income (EBITDA) 202 185
Leverage
(Debt/EBITDA)
- -
Capital Expenditure - 29,7
Free Cash Flow (FCF) - 132
Book Value Per Share (BVPS) (  ) - -
Cash Flow per Share (  ) - -
Announcement Date -
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 1 633 M $ -
Valuation 2020e 2021e
P/E ratio (Price / EPS) 19,2x 17,9x
Capitalization / Revenue 1,12x 1,13x
Yield (DPS / Price) 1,58% 1,58%
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 9,09% 8,70%
Operating Leverage (Delta EBIT / Delta Sales) -3,06x -4,90x
Net Margin (Net Profit / Revenue) 5,83% 6,36%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend 30,3% 28,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   2,04% 2,23%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
BNA & Dividende